Tango Therapeutics, Inc. (TNGX) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts TNGX Hot Sheet
Join SI Premium – FREE
Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q1 EPS of ($0.32), $0.01 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- HSBC Downgrades Hermes International (RMS:FP) (HESAY) to Hold
- A. O. Smith CEO Stephen Shafer named chairman
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
